Matt Timmers

Matt Timmers is a Research Fellow in Biomedical Engineering at Eindhoven University of Technology (TU/e), specializing in Precision Medicine. His work focuses on nanocarrier technologies for drug delivery systems, click chemistry applications, and biomedical materials design. He holds dual doctoral degrees (Dr.ir.) and has authored/co-authored multiple peer-reviewed articles in high-impact journals like Nature Nanotechnology and Chemistry: A European Journal.

Key research interests include developing modular nanoparticle platforms for vaccines, pH-sensitive drug release mechanisms, and redox-triggered peptide release systems. His collaborative projects involve multidisciplinary teams from institutions such as Leiden University Medical Center and Maastricht University. Timmers has pioneered novel silicon-based linkers and sulfoximine compounds for biomedical applications, with applications in cancer therapy and immunotherapy.

• 2025: Lead development of modular nanoparticle vaccine platform (Nature Nanotechnology)
• 2023: Published breakthrough redox-triggered nanocarrier system (Bioconjugate Chemistry)
• 2019: Completed Master's thesis on perylene diimides in lipid bilayer interactions

His research contributes to UN Sustainable Development Goals related to good health and well-being through advancements in targeted drug delivery and precision medicine technologies.